VentureMed Group Closes $28M Series C Led by S3 Ventures

Why It Matters

The capital injection enables VentureMed to scale its market presence and advance its pipeline, potentially increasing its competitive foothold in the medical device sector and delivering new solutions to healthcare providers.

Deal Summary

VentureMed Group, a Minneapolis-based medical device company, closed a $28M Series C financing round led by S3 Ventures with participation from existing investor Endeavour Vision. The company will use the funds to expand commercial infrastructure, advance its clinical program and support new product development.